Some of functionality may not work while you disabled JavaScript. Enable JavaScript for better User Exprience.
Access here alternative investment news about System1 Announces A $25M Series A Funding To Advance Integrated Technology Platform For Neurotherapeutics Discovery
Venture Capital

System1 Announces A $25M Series A Funding To Advance Integrated Technology Platform For Neurotherapeutics Discovery

by vcaonline.com posted 2months ago 158 views
System1 Announces a $25 Million Series A Funding to Advance Integrated Technology Platform for Neurotherapeutics Discovery SAN FRANCISCO, September 12, 2018-- System1 Biosciences, Inc, a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for neurological and psychiatric disorders, today announced the completion of $25 million in Series A financing. The round was co-led by CRV and Pfizer Ventures with participation from Alexandria Venture Investments, Dolby Family Ventures, Longevity Fund, Riot Ventures, Kinled Holding, Wilmot Ventures, Webb Investment Network, Liquid 2 Ventures, and Boom Capital.

In this article